[APASL2014]Entecavir for CHB: A Chinese Clinical Perspective
——  作者:J.L.Hou    时间:2014-03-19     阅读数: 99

简介:In a 5-year, longitudinal study assessing the efficacy of entecavir (ETV) versus other standard-or-care therapies, Dr. Hou and colleagues revealed that ETV therapy resulted in a 85% virological response, compared with 67% overall with all other treatments.

请登录后查看详细内容

发表评论

全部评论